Greenway Medical Technologies, Inc., (NYSE: GWAY), which delivers innovative software and business services solutions for ambulatory care providers through its PrimeSUITE® platform, will release its financial results for the three months ended Sept. 30, 2012, after the securities markets close on Thursday, Nov. 1, 2012.
Greenway senior executives will review operating and financial highlights during a live teleconference for investors scheduled for 5 p.m. Eastern time that day. Persons interested in participating in the call should dial (866) 831-6224 or (617) 213-8853 for international calls. The participant passcode is 54208348. The investor conference call can also be accessed through the Investors section of Greenway’s website, www.greenwaymedical.com/investors. A replay of the teleconference will be available at that location shortly after the call, through Dec. 15.
About Greenway and PrimeSUITE
Greenway Medical Technologies, Inc. (NYSE: GWAY) delivers smarter solutions for smarter healthcare ™. PrimeSUITE ® — Greenway’s certified and fully integrated electronic health record, practice management and interoperability solution — helps improve care coordination, quality and cost-efficiency as part of a smarter, sustainable healthcare system. Thousands of providers across more than 30 specialties and sub-specialties use on-premise or cloud-based Greenway ® solutions in healthcare enterprises, physician practices and ambulatory clinics nationwide. For details, see greenwaymedical.com, Twitter, Facebook or YouTube .Greenway, the Greenway logo and PrimeSUITE are registered trademarks and the phrase “smarter solutions for smarter healthcare” is a trademark of Greenway Medical Technologies, Inc. Other product or company names are the property of their respective owners.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts